Beyond molecular classification: integrating signaling, subcellular, and immune reprogramming in endometrial cancer
Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with rising incidence rates that have not been matched by equivalent improvements in survival outcomes, particularly for high-grade and advanced-stage disease. The landmark molecular profiling performed by The Cancer Genome Atla...